The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6/E7 transcript in cervical carcinoma C33-A cells

Archives of Virology

Volumn 155, Issue 12, 2010, Pages 1959-1970

  del Moral Hernández, Oscar ^a   López Urrutia, Eduardo ^a   Bonilla Moreno, Raúl ^a   Martínez Salazar, Martha ^a   Arechaga Ocampo, Elena ^b   Berumen, Jaime ^c,d   Villegas Sepúlveda, Nicolás ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PROTEIN E7; VIRUS RNA;

ARTICLE; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; RNA SPLICING; TUMOR CELL LINE;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN BIOSYNTHESIS; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 78449299898     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0787-9     Document Type: Article

References (46)

1. zur Hausen H (2008) Papillomavirus-to vaccination and beyond. Biochemistry 73: 498-503.
2. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer FX, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
3. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421.
4. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905-3910.
5. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR, Schiller JT (1991) The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol 65: 4860-4866.
6. Münger K, Howley PM (2002) Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228.
7. Schneider-Gädicke A, Schwarz E (1986) Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 5: 2285-2292.
8. Smotkin D, Berek JS, Fu YS, Hacker NF, Major FJ, Wettstein FO (1986) Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 68: 241-244.
9. Milligan SG, Veerapraditsin T, Ahamet B, Mole S, Graham SV (2007) Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360: 172-181.
10. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B (2004) Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 74: 107-116.
11. Smotkin D, Prokoph H, Wettstein FO (1989) Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 63: 1441-1447.
12. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61: 962-971.
13. Snijders PJF, van den Brule AJC, Schrijnemakers HFJ, Raaphorst PMC, Meijer CJLM, Walboomers JMM (1992) Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly (A) sites. J Virol 66: 3172-3178.
14. De la Rosa-Rios MA, Martínez-Salazar M, Martínez-Garcia M, González-Bonilla C, Villegas-Sepúlveda N (2006) The intron 1 of HPV 16 has a suboptimal branch point at a guanosine. Virus Res 118: 46-54.
15. Zabolotny JM, Krummenacher C, Fraser NW (1997) The herpes simplex virus type 12. 0-kilobase latency-associated transcript is a stable intron which branches at guanosine. J Virol 71: 4199-4208.
16. Dyhr-Mikkelsen H, Kjems J (1995) Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. J Biol Chem 270: 24060-24066.
17. Stacey SN, Jordan D, Snijders PJF, Mackett M, Walboomers JMM, Arrand JR (1995) Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J Virol 69: 7023-7031.
18. Kozak M (2002) Pushing the limits of the scanning mechanism for initiation of translation. Gene 299: 1-34.
19. Roggenbuck B, Larsen PM, Fey SJ, Bartsch D, Gissmann L, Schwarz E (1991) Human papillomavirus type 18 E6*, E6, and E7 protein synthesis in cell-free translation systems and comparison of E6 and E7 in vitro translation products to proteins immunoprecipitated from human epithelial cells. J Virol 65: 5068-5072.
20. Tang S, Tao M, McCoy JP Jr, Zheng Z-M (2006) The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249-4263.
21. Tan TM, Gloss B, Bernard HU, Ting RCY (1994) Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. J Gen Virol 75: 2663-2670.
22. Stacey SN, Jordan D, Williamson AJK, Brown M, Coote JH, Arrand JR (2000) Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J Virol 74: 7284-7297.
23. McNicol P, Guijon F, Wayne S, Hidajat R, Paraskevas M (1995) Expression of human papillomavirus type 16 E6-E7 open reading frame varies quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. J Clin Microbiol 33: 1169-1173.
24. Ordoñes RM, Espinoza AM, Sanchez-Gonzalez DJ, Armendariz-Borunda J, Berumen J (2004) Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gral Virol 85: 1433-1444.
25. Doorbar J, Parton A, Hartley K, Banks L, Crook T, Stanley M, Crawford L (1990) Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178: 254-262.
26. Arechaga-Ocampo E, Pereira-Suarez AL, del Moral-Hernandez O, Cedillo-Barron L, Rodriguez-Sastre MA, Castillo-Alvarez A, Lopez-Bayghen E, Villegas-Sepúlveda N (2008) HPV+ cervical carcinomas and cell lines display altered expression of Caspases. Gynecol Oncol 108: 10-18.
27. Zhuang Y, Goldstein AM, Weiner AM (1989) UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci USA 86: 2752-2756.
28. Jordan M, Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33: 136-143.
29. Cricca M, Venturoli S, Leo E, Costa S, Musiani M, Zerbini M (2009) Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. J Med Virol 8: 1276-1282.
30. Scheurer ME, Dillon LM, Chen Z, Follen M, Adler-Storthz K (2007) Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect Agent Cancer 2: 8.
31. MacMillan AM, Querry CC, Allerson CR, Chen S, Verdine GL, Sharp PA (1994) Dynamic association of proteins with pre-mRNA Branch region. Genes Dev 8: 3008-3020.
32. Shirasawa H, Tanzawa H, Matsunaga T, Simizu B (1991) Quantitative detection of spliced E6-E7 transcripts of human papillomavirus type 16 in cervical premalignant lesions. Virology 184: 795-798.
33. De la Cruz-Hernández E, García-Carrancá A, Mohar-Betancourt A, Dueñas-González A, Contreras-Paredes A, Pérez-Cardenas E, Herrera-Goepfert R, Lizano-Soberón M (2005) Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 86: 2459-2468.
34. Zhao X, Oberg D, Rush M, Fay J, Lambkin H, Schwartz S (2005) A 57-nucleotide upstream early polyadenilation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2 and polypirimidine tract binding protein. J Virol 79: 4270-4288.
35. Grosso AR, Martins S, Carmo-Fonseca M (2008) The emerging role of splicing factors in cancer. EMBO Rep 9: 1087-1093.
36. Perrotti D, Calabretta B (2002) Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 21: 8577-8583.
37. Somberg M, Zhao X, Fröhlich M, Evander M, Schwartz S (2008) Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5′ splice site, SD3632. J Virol 82: 3665-3678.
38. McPhillips MG, Veerapraditsin T, Cumming SA, Karali D, Milligan SG, Boner W, Morgan IM, Graham SV (2004) SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J Virol 78: 10598-10605.
39. Shai A, Brake T, Somoza C, Lambert PF (2007) The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 67: 1626-1635.
40. Shally M, Alloul N, Jackman A, Muller M, Gissmann L, Sherman L (1996) The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53. Virus Res 42: 81-96.
41. Favia G, Kanduc D, Lo Muzio L, Lucchese A, Serpico R (2004) Possible association between HPV16 E7 protein level and cytokeratin 19. Int J Cancer 111: 795-797.
42. Scheffner M, Münger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88: 5523-5527.
43. Guccione E, Pim D, Banks L (2004) HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner. Int J Cancer 100: 928-933.
44. Pim D, Banks L (1999) HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18: 7403-7408.
45. Pim D, Tomaic V, Banks L (2009) The HPV E6* proteins from high-risk, mucosal human papillomaviruses can direct the degradation of cellular proteins in the absence of full-length E6 protein. J Virol 83: 9863-9874.
46. Filippova M, Johnson MM, Bautista M, Filippov V, Fodor N, Tungteakkhun SS, Williams K, Duerksen-Hughes PJ (2007) The large and small isoforms of HPV 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol 81: 4116-4129.